Prolonged response of recurrent IDH-wild-type glioblastoma to laser interstitial thermal therapy with pembrolizumab

Authors

Helen Hwang, Washington University School of Medicine in St. Louis
Jiayi Huang, Washington University School of Medicine in St. Louis
Karam Khaddour, Washington University School of Medicine in St. Louis
Omar H Butt, Washington University School of Medicine in St. Louis
George Ansstas, Washington University School of Medicine in St. Louis
Jie Chen, Washington University School of Medicine in St. Louis
Ruth Gn Katumba, Washington University School of Medicine in St. Louis
Albert H Kim, Washington University School of Medicine in St. Louis
Eric C Leuthardt, Washington University School of Medicine in St. Louis
Jian L Campian, Washington University School of Medicine in St. Louis

Journal

CNS Oncology

Publication Date

3-1-2022

Volume

11

Issue

1

First Page

CNS81

Document Type

Open Access Publication

DOI

10.2217/cns-2021-0013

Rights and Permissions

Hwang H, Huang J, Khaddour K, Butt OH, Ansstas G, Chen J, Katumba RG, Kim AH, Leuthardt EC, Campian JL. Prolonged response of recurrent IDH-wild-type glioblastoma to laser interstitial thermal therapy with pembrolizumab. CNS Oncol. 2022 Mar 1;11(1):CNS81. doi: 10.2217/cns-2021-0013. This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License. To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/4.0/. For full bibliographic citation, please refer to the version available at www.futuremedicine.com.

Recommended Citation

Hwang, Helen; Huang, Jiayi; Khaddour, Karam; Butt, Omar H; Ansstas, George; Chen, Jie; Katumba, Ruth Gn; Kim, Albert H; Leuthardt, Eric C; and Campian, Jian L, "Prolonged response of recurrent IDH-wild-type glioblastoma to laser interstitial thermal therapy with pembrolizumab." CNS Oncology. 11, 1. CNS81 (2022).
https://digitalcommons.wustl.edu/oa_4/409